Atopic eczema/dermatitis syndrome – a genetically complex disease. New advances in discovering the genetic contribution
Atopic eczema/dermatitis syndrome – a genetically complex disease. New advances in discovering the genetic contribution
复制标题
特应性湿疹/皮炎综合征——一种复杂的遗传疾病,发现遗传因素的新进展。
DOI:
10.1034/j.1398-9995.2003.02162.x
复制
发表时间:
2003
期刊:
影响因子:
12.4
通讯作者:
T. Bieber
中科院分区:
文献类型:
--
作者:
H. Klüken;T. Wienker;T. Bieber
Due to recent developments in molecular genetics great progress has been achieved in understanding the etiology of human genetic diseases. Presumably, most causative genes for monogenic diseases will be known within the next few years. However, this progress is mainly limited to the rare monogenic diseases. Since Cloninger (1) – searching for genes predisposing to schizophrenia – stated a complex hypotheses about the inheritance of schizophrenia, a shift within medical genetics started, from the focus on monogenic diseases to genetically complex diseases. Still, in most contexts, talk about being postgenomic seems a little premature. Post-Mendelian seems more accurate as we move from an era in which genetics has been rooted in monogenic diseases with high penetrance to a greater awareness (but limited understanding) of polygenic diseases and traits often with relatively low penetrance. The etiology of complex diseases is multifactorial and based on several interacting genetic mechanisms and additional environmental factors. Today, many diseases like arterial hypertension, diabetes mellitus, inflammatory bowel disease, epilepsy, schizophrenia, migraine, psoriasis, asthma and atopic eczema/dermatitis syndrome (AEDS) are seen as genetically complex. Generally, they have a much higher population prevalence than the rare monogenic diseases, hence an improved understanding of the pathology of complex diseases is highly relevant in socioeconomic terms. The present review is aimed to focus on research results on AEDS as a complex disease with a multifactorial pathophysiologic background. The nomenclature of allergic diseases is used according to the EAACI Nomenclature Position Paper (2).
登录
查看更多内容
影响因子:
12.4
作者:
Marsh,DG
通讯作者:
Marsh,DG
影响因子:
56.9
作者:
MARSH, DG;NEELY, JD;BEATY, TH
通讯作者:
BEATY, TH
影响因子:
6.5
作者:
Beyer, K;Nickel, R;Wahn, U
通讯作者:
Wahn, U
影响因子:
9.8
作者:
Xu, JF;Meyers, DA;Cox, NJ
通讯作者:
Cox, NJ
DOI:
--
发表时间:
1999
期刊:
Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.
影响因子:
--
作者:
Ober,C;Tsalenko,A;Willadsen,S;Newman,D;Daniel,R;Wu,X;Andal,J;Hoki,D;Schneider,D;True,K;Schou,C;Parry,R;Cox,N
通讯作者:
Cox,N